MedicaNatumin is a self-care group based in Habo and Jönköping, focusing on developing and marketing healthcare products based on innovative ingredients and solid research.

Our goal is to contribute to a positive health trend and to provide improved quality of life through products that treat or support the human body’s functions.

Among our product categories are dietary supplements, medical devices and dermatological and cosmetic products. Among the brands are leading dietary supplements like L-Argiplex and Nypozin and the scientifically documented skin care series Jabushe.

The foundation of MedicaNatumin’s business is to offer innovative products and strong brands from a sustainable and scientific base.
Our starting point is to have a strong position on the Nordic market while developing international partnerships and export operations.

We have all essential parts of the organisation; innovation and product development based on a strong patent platform, a local production that meets strict hygiene and quality requirements, a well-functioning sales and marketing department, and the entire organization is penetrated by clear roles and responsibilities.

Shares

Aktiestruktur

Antal aktier	375 989 277
Summa emitterat	375 989 277
Antal aktieägare	1 867 st
Antal teckningsoptioner	16 300 000 (1 option = 1 aktie)
ISIN	Aktie SE0001789793

Statistik

Först	0.616
Högst	0.616
Medel	0.573
Lägst	0.550
Senast	0.582
+/- Sek	-0.02
+/- %	-3.00
Omsättning	492756.726
Volym	859755
ISIN	SE0001789793

Aktieägare

Aktieägare	Antal aktier	Andel (ca)
N.P.H i Habo AB	75 000 000	19,95%
Swedbank Försäkring AB	39 579 000	10,53%
Försäkringsbolaget, Avanza Pension	36 561 476	9,72%
TJ Gruppen AB	18 194 055	4,84%
Jool Invest AB	17 448 434	4,64%
Lars-Olof Johansson	8 883 360	2,36%
Jesper Pettersson	8 500 000	2,26%
Jörgen Wehmonen	6 720 660	1,79%
Karl-Olov Eriksson	6 119 725	1,63%
Nordnet Pensionsförsäkring AB	5 376 366	1,43%
Summa	222 383 076	59,15%
Övriga 1 904 aktieägare	153 606 201	40,85%
Totalt antal aktier	375 989 277	100,00 %